secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aditxt, Inc. (ADTX)
CIK:        0001726711
Form:       8-K
Filed at:   2024-05-08T23:59:59+00:00
Accession:  0001213900-24-040875
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 5.03, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aditxt raises $4.2M in private placement of convertible preferred and warrants
------------------------------------------------------------------------------

- Gross proceeds $4.2M from sale of 4,186 Series C-1 convertible preferred shares, 4,186 Series D-1 voting preferred shares, and warrants for ~1.6M common shares.
- Series C-1 convertible at $2.595/share; warrants exercisable at $2.47/share for 5 years, beginning 6 months after issuance.
- Company to use $1.0M of net proceeds for merger obligations with Evofem Biosciences; remainder for working capital.
- Placement agent Dawson James receives 7% cash fee and warrants for 5% of securities sold.
- Private placement expected to close on or about May 6, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1726711/000121390024040875/0001213900-24-040875-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1726711/000121390024040875/ea0205527-8k_aditxt.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-040875

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer